ArticleEuropean journal of human genetics : EJHG2026
Advancing training on genetic therapies: a multi-specialty survey highlighting the role of medical geneticists.
Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This cross-sectional online survey study explores the landscape of medical training on genetic therapies, assessing the experience, expectations and attitudes of medical geneticists, other specialists, and medical trainees in Canada and USA. Among the 315 participants, only 17% reported being "very familiar" with genetic therapies, and 70% expressed dissatisfaction with current training in this area. Across all groups, there was a consistently low level of satisfaction with existing training on genetic therapies, coupled with a strong consensus that this topic should be better integrated into medical programs. Physicians with specialization in genetics reported the highest familiarity and the most experience in teaching about genetic therapies, covering a broader range of topics than other specialties. All specialties acknowledged the pivotal role of medical geneticists in advancing education on genetic therapies. Instead of each specialty designing their own fellowship programs independently, there was a clear preference to do so in collaboration with medical geneticists. Furthermore, most respondents advocated for the introduction of genetic therapy education earlier in medical training, during medical school and residency programs. Our study highlights a clear and pressing need for comprehensive, stage-specific education reform about genetic therapies. Medical geneticists are uniquely positioned to lead and support these educational efforts, ensuring the successful adoption of advanced genetic therapies in patient care.
Identifiers
42082643What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.